The JAMA paper provides a solid foundation for improving weight loss conversations and the data are both compelling and important. But without LLM-powered solutions, these recommendations risk ...
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 ...
Four papers published in JAMA, JAMA Neurology and JAMA Network Open look at Amyotrophic Lateral Sclerosis (ALS) treatment results from the HEALY ALS Platform Trial. Dr Ahmad Al Khleifat, Senior ...
7d
News Medical on MSNGroundbreaking ALS platform trial accelerates research and drug testingAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results